Patient Square Bets Big on NKTR: A Deep Dive for Investors
A prominent investor placed a sizable stake in Nektar Therapeutics, sparking questions about the stock's potential. T...
This section ranks key world stock indices and explains the metrics behind rankings, helping readers compare market breadth.
22,503 articlesA prominent investor placed a sizable stake in Nektar Therapeutics, sparking questions about the stock's potential. T...
Oracle is set to report its June quarter as AI demand tests the cloud backbone. Backlog and RPO could reveal real app...
As the Fed holds rates, income-focused investors seek reliable yields. This article highlights two dividend stocks ev...
As two iconic U.S. food brands, Krispy Kreme and McDonald’s attract very different types of investors. This article b...
Transocean (Rig) 2025 earnings could hinge on fleet utilization and day rates. This guide unpackages the drivers, ris...
Remitly (RELY) is evolving beyond simple transfers. This in-depth analysis walks through expected 2025 earnings drive...
JPMorgan Chase has built a long runway of dividend growth, but is it the best dividend stock in banking for your port...
Bark is shaping its path in a competitive pet market. This guide breaks down what to expect in bark (bark) 2026 earni...
A veteran CIO warns that even stellar AI earnings may not keep momentum, suggesting the market is testing whether thi...
SpaceX aims to put AI compute in orbit by 2028, a move that could reshape data centers. This article breaks down the ...
When a former chief officer sells stock, investors should look beyond the headline. This guide explains why insider m...
A major hydration company with billion-dollar revenue just welcomed a new investor stake, sending shares higher. This...